Rino Rappuoli
Research Subjects
Rino Rappuoli has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Mariagrazia Pizza
From *IRIS, Chiron S.p.A., 53100 Siena, Italy; and the ‡Department of Biochemistry, Imperial College of Science, Technology and Medicine, London, SW7 2AY, United Kingdom
3 shared publicationsGiuseppe Del Giudice
<!--label omitted: 2-->IRIS, Chiron SpA Immunobiological Research Institute Siena, 53100 Siena,2 Italy
2 shared publicationsA. Covacci
IRIS
1 shared publicationA. Guarino
1 shared publicationC. Lange
IRIS
1 shared publicationC. Wülfing
IRIS, Chiron Vaccines Immunobiological Research Institute Siena, Via Fiorentina 1, 53100 Siena, Italy
1 shared publication
Latest Publications
- 1 June 1999
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 67 (6) , 3112-3120
A Conventional Beagle Dog Model for Acute and Chronic Infection withHelicobacter pylori
Helicobacter pylorihas been widely recognized as an important human pathogen responsible for chronic gastritis, peptic ulcers, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. Little is known about the natural history of this infection since patients are usually recognized as having the infection only after years or decades of chronic disease. Several animal models ofH. pyloriinfection, including those with different species of rodents, nonhuman primates, and germ-free animals, have been developed. Here we describe a new animal model in which the clinical, pathological, microbiological, and immunological aspects of human acute and chronic infection are mimicked and which allows us to monitor these aspects of infection within the same individuals. Conventional Beagle dogs were infected orally with a mouse-adapted strain ofH. pyloriand monitored for up to 24 weeks. Acute infection caused vomiting and diarrhea. The acute phase was followed by polymorphonuclear cell infiltration, interleukin 8 induction, mononuclear cell recruitment, and the appearance of a specific antibody response againstH. pylori. The chronic phase was characterized by gastritis, epithelial alterations, superficial erosions, and the appearance of the typical macroscopic follicles that in humans are considered possible precursors of MALT lymphoma. In conclusion, infection in this model mimics closely human infection and allows us to study those phases that cannot be studied in humans. This new model can be a unique tool for learning more about the disease and for developing strategies for treatment and prevention.
- 1 June 1999
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 67 (6) , 3112-3120
A Conventional Beagle Dog Model for Acute and Chronic Infection withHelicobacter pylori
Helicobacter pylorihas been widely recognized as an important human pathogen responsible for chronic gastritis, peptic ulcers, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. Little is known about the natural history of this infection since patients are usually recognized as having the infection only after years or decades of chronic disease. Several animal models ofH. pyloriinfection, including those with different species of rodents, nonhuman primates, and germ-free animals, have been developed. Here we describe a new animal model in which the clinical, pathological, microbiological, and immunological aspects of human acute and chronic infection are mimicked and which allows us to monitor these aspects of infection within the same individuals. Conventional Beagle dogs were infected orally with a mouse-adapted strain ofH. pyloriand monitored for up to 24 weeks. Acute infection caused vomiting and diarrhea. The acute phase was followed by polymorphonuclear cell infiltration, interleukin 8 induction, mononuclear cell recruitment, and the appearance of a specific antibody response againstH. pylori. The chronic phase was characterized by gastritis, epithelial alterations, superficial erosions, and the appearance of the typical macroscopic follicles that in humans are considered possible precursors of MALT lymphoma. In conclusion, infection in this model mimics closely human infection and allows us to study those phases that cannot be studied in humans. This new model can be a unique tool for learning more about the disease and for developing strategies for treatment and prevention.
- 1 June 1998
- Published by Springer Nature in Folia Microbiologica
- Vol. 43 (3) , 275-278
Pathogenicity island mediatesHelicobacter pylori interaction with the host
InHelicobacter pylori, a pathogenicity island (PAI) of approximately 40 kb, namedcag, is present in a subset of strains. The strains containing the PAI are more virulent than those that do not contain it, and are associated with peptic ulcer and gastric cancer. A putative secretory mechanism is encoded by this PAI. This secretory system is thought to be involved in the induction of the proiflammatory lymphokine IL-8 and tyrosine phosphorylation of proteins in the gastric cells. We are currently investigating the potential toxic factors exported or encoded by this region.
- 1 June 1998
- Published by Springer Nature in Folia Microbiologica
- Vol. 43 (3) , 275-278
Pathogenicity island mediatesHelicobacter pylori interaction with the host
InHelicobacter pylori, a pathogenicity island (PAI) of approximately 40 kb, namedcag, is present in a subset of strains. The strains containing the PAI are more virulent than those that do not contain it, and are associated with peptic ulcer and gastric cancer. A putative secretory mechanism is encoded by this PAI. This secretory system is thought to be involved in the induction of the proiflammatory lymphokine IL-8 and tyrosine phosphorylation of proteins in the gastric cells. We are currently investigating the potential toxic factors exported or encoded by this region.
- Open Access
- 6 April 1998
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 187 (7) , 1123-1132
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
Heat-labile Escherichia coli enterotoxin (LT) has the innate property of being a strong mucosal immunogen and adjuvant. In the attempt to reduce toxicity and maintain the useful immunological properties, several LT mutants have been produced. Some of these are promising mucosal adjuvants. However, so far, only those that were still toxic maintained full adjuvanticity. In this paper we describe a novel LT mutant with greatly reduced toxicity that maintains most of the adjuvanticity. The new mutant (LTR72), that contains a substitution Ala → Arg in position 72 of the A subunit, showed only 0.6% of the LT enzymatic activity, was 100,000-fold less toxic than wild-type LT in Y1 cells in vitro, and was at least 20 times less effective than wild-type LT in the rabbit ileal loop assay in vivo. At a dose of 1 μg, LTR72 exhibited a mucosal adjuvanticity, similar to that observed with wild-type LT, better than that induced by the nontoxic, enzymatically inactive LTK63 mutant, and much greater than that of the recombinant B subunit. This trend was consistent for both the amounts and kinetics of the antibody induced, and priming of antigen-specific T lymphocytes. The data suggest that the innate high adjuvanticity of LT derives from the independent contribution of the nontoxic AB complex and the enzymatic activity. LTR72 optimizes the use of both properties: the enzymatic activity for which traces are enough, and the nontoxic AB complex, the effect of which is dose dependent. In fact, in dose–response experiments in mice, 20 μg of LTR72 were a stronger mucosal adjuvant than wild-type LT. This suggests that LTR72 may be an excellent candidate to be tested in clinical trials.
- 6 April 1998
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 187 (7) , 1123-1132
Open AccessMucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
Heat-labile Escherichia coli enterotoxin (LT) has the innate property of being a strong mucosal immunogen and adjuvant. In the attempt to reduce toxicity and maintain the useful immunological properties, several LT mutants have been produced. Some of these are promising mucosal adjuvants. However, so far, only those that were still toxic maintained full adjuvanticity. In this paper we describe a novel LT mutant with greatly reduced toxicity that maintains most of the adjuvanticity. The new mutant (LTR72), that contains a substitution Ala → Arg in position 72 of the A subunit, showed only 0.6% of the LT enzymatic activity, was 100,000-fold less toxic than wild-type LT in Y1 cells in vitro, and was at least 20 times less effective than wild-type LT in the rabbit ileal loop assay in vivo. At a dose of 1 μg, LTR72 exhibited a mucosal adjuvanticity, similar to that observed with wild-type LT, better than that induced by the nontoxic, enzymatically inactive LTK63 mutant, and much greater than that of the recombinant B subunit. This trend was consistent for both the amounts and kinetics of the antibody induced, and priming of antigen-specific T lymphocytes. The data suggest that the innate high adjuvanticity of LT derives from the independent contribution of the nontoxic AB complex and the enzymatic activity. LTR72 optimizes the use of both properties: the enzymatic activity for which traces are enough, and the nontoxic AB complex, the effect of which is dose dependent. In fact, in dose–response experiments in mice, 20 μg of LTR72 were a stronger mucosal adjuvant than wild-type LT. This suggests that LTR72 may be an excellent candidate to be tested in clinical trials.
- 1 April 1998
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 66 (4) , 1648-53
A Recombinant Live Attenuated Strain of Vibrio cholerae Induces Immunity against Tetanus Toxin and Bordetella pertussis Tracheal Colonization Factor
An attenuated strain of Vibrio cholerae was used as a carrier for the expression of heterologous antigens such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf). In vitro, high levels of protein were obtained when the Escherichia coli nirB promoter was used and the bacteria were grown with low aeration. Intranasal immunization of mice with IEM101 expressing TetC elicited serum vibriocidal activity and induced antibodies against tetanus toxin which were protective against lethal challenge with 10 times the 50% lethal dose of tetanus toxin. Bacterial viability was essential for the induction of anti-TetC antibodies. Intranasal administration of IEM101 expressing Tcf induced a significant reduction in bacterial colonization of the tracheas of mice challenged with wild-type B. pertussis . These data are in agreement with the putative role of Tcf in Bordetella tracheal colonization. In conclusion, we have demonstrated that V. cholerae may be used as a live vector to deliver heterologous antigens in vivo and that protection to both systemic and local challenge may be achieved.
- 1 April 1998
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 66 (4) , 1648-53
A Recombinant Live Attenuated Strain of Vibrio cholerae Induces Immunity against Tetanus Toxin and Bordetella pertussis Tracheal Colonization Factor
An attenuated strain of Vibrio cholerae was used as a carrier for the expression of heterologous antigens such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf). In vitro, high levels of protein were obtained when the Escherichia coli nirB promoter was used and the bacteria were grown with low aeration. Intranasal immunization of mice with IEM101 expressing TetC elicited serum vibriocidal activity and induced antibodies against tetanus toxin which were protective against lethal challenge with 10 times the 50% lethal dose of tetanus toxin. Bacterial viability was essential for the induction of anti-TetC antibodies. Intranasal administration of IEM101 expressing Tcf induced a significant reduction in bacterial colonization of the tracheas of mice challenged with wild-type B. pertussis . These data are in agreement with the putative role of Tcf in Bordetella tracheal colonization. In conclusion, we have demonstrated that V. cholerae may be used as a live vector to deliver heterologous antigens in vivo and that protection to both systemic and local challenge may be achieved.
- 5 February 1998
- Published by Springer Nature in Archives of Microbiology
- Vol. 169 (2) , 113-119
Effects of the insertion of a nonapeptide from murine IL-1β on the immunogenicity of carrier proteins delivered by live attenuated Salmonella
A nonapeptide from IL-1β has been reported to be an immunostimulant and adjuvant. To investigate the possibility of enhancing the immunogenicity of recombinant antigens delivered by live-attenuated Salmonella strains, we inserted an oligonucleotide coding for the nonapeptide from murine IL-1β into the genes of three model proteins: LamB, MalE, and flagellin. The hybrid proteins were expressed and delivered in vivo by Salmonella aroA strains, and serum antibody responses were analyzed. The results showed that the nonapeptide induced an increase in the immune response against Salmonella-delivered flagellin, measured on day 28 post-immunization. However, the adjuvant effect was lost by day 42. In no case was an adjuvant effect detected for Salmonella-delivered LamB or MalE. Thus, by comparing the immune responses raised by purified MalE with and without the peptide, we investigated whether the insertion of the peptide affected the immunogenicity of the protein itself. Also in this case, a modest adjuvant effect was shown only after primary immunization and when very low doses of antigen were used. In conclusion, the immunomodulatory properties of the IL-1β peptide can also be detected when it is delivered in vivo by Salmonella; however, the effect is modest and antigen-dependent.
- 5 February 1998
- Published by Springer Nature in Archives of Microbiology
- Vol. 169 (2) , 113-119
Effects of the insertion of a nonapeptide from murine IL-1β on the immunogenicity of carrier proteins delivered by live attenuated Salmonella
A nonapeptide from IL-1β has been reported to be an immunostimulant and adjuvant. To investigate the possibility of enhancing the immunogenicity of recombinant antigens delivered by live-attenuated Salmonella strains, we inserted an oligonucleotide coding for the nonapeptide from murine IL-1β into the genes of three model proteins: LamB, MalE, and flagellin. The hybrid proteins were expressed and delivered in vivo by Salmonella aroA strains, and serum antibody responses were analyzed. The results showed that the nonapeptide induced an increase in the immune response against Salmonella-delivered flagellin, measured on day 28 post-immunization. However, the adjuvant effect was lost by day 42. In no case was an adjuvant effect detected for Salmonella-delivered LamB or MalE. Thus, by comparing the immune responses raised by purified MalE with and without the peptide, we investigated whether the insertion of the peptide affected the immunogenicity of the protein itself. Also in this case, a modest adjuvant effect was shown only after primary immunization and when very low doses of antigen were used. In conclusion, the immunomodulatory properties of the IL-1β peptide can also be detected when it is delivered in vivo by Salmonella; however, the effect is modest and antigen-dependent.
- 15 October 1997
- Published by Springer Nature in Archives of Microbiology
- Vol. 168 (5) , 437-440
Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point.
- 15 October 1997
- Published by Springer Nature in Archives of Microbiology
- Vol. 168 (5) , 437-440
Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point.
- 15 April 1997
- Published by Springer Nature in Archives of Microbiology
- Vol. 167 (5) , 280-283
Efficient production of heat-labile enterotoxin mutant proteins by overexpression of dsbA in a degP -deficient Escherichia coli strain
Escherichia coli heat-labile enterotoxin (LT) mutants containing Val60→Gly or Ser114→Lys substitutions in the A subunit do not produce the A subunit efficiently in E. coli. These mutants accumulate mostly the B pentamer devoid of the A subunit in the periplasmic space. Here we show that overproduction of the periplasmic chaperone DsbA, which is involved in disulfide bond formation, in a strain deficient in the periplasmic protease DegP allows efficient production of the mutant LT molecules. Our results suggest that the formation of the oligomeric toxin is influenced by DsbA, which helps protein folding, and by DegP, which removes the folded intermediates that can be untoxic for the cell.
- 15 April 1997
- Published by Springer Nature in Archives of Microbiology
- Vol. 167 (5) , 280-283
Efficient production of heat-labile enterotoxin mutant proteins by overexpression of dsbA in a degP -deficient Escherichia coli strain
Escherichia coli heat-labile enterotoxin (LT) mutants containing Val60→Gly or Ser114→Lys substitutions in the A subunit do not produce the A subunit efficiently in E. coli. These mutants accumulate mostly the B pentamer devoid of the A subunit in the periplasmic space. Here we show that overproduction of the periplasmic chaperone DsbA, which is involved in disulfide bond formation, in a strain deficient in the periplasmic protease DegP allows efficient production of the mutant LT molecules. Our results suggest that the formation of the oligomeric toxin is influenced by DsbA, which helps protein folding, and by DegP, which removes the folded intermediates that can be untoxic for the cell.
- 1 April 1997
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 24 (4) , 460
HELICOBACTER PYLORI VACUOLATING TOXIN INDUCES Ca2+-MEDIATED Cl--SECRETION IN CACO-2 CELLS.
- 1 April 1997
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 24 (4) , 460
HELICOBACTER PYLORI VACUOLATING TOXIN INDUCES Ca2+-MEDIATED Cl--SECRETION IN CACO-2 CELLS.
- 1 August 1996
- Published by Wiley in Molecular Microbiology
- Vol. 21 (4) , 667-674
Three conserved consensus sequences identify the NAD‐binding site of ADP‐ribosylating enzymes, expressed by eukaryotes, bacteria and T‐even bacteriophages
It has been previously reported that the three‐dimensional structures of the NAD‐binding and catalytic site of bacterial toxins with ADP‐ribosylating activity are superimposable, and that the key amino acids for the enzymatic activity are conserved. The model includes an NAD‐binding and catalytic site formed by an α‐helix bent over a β‐strand, surrounded by two β‐strands bearing a Glu and a His, or Arg, that are required for catalysis. We show here that the model can be extended to comprise all proteins with ADP‐ribosylating activity known to date, including all eukaryotic mono‐ and poly‐ADP‐ribosyltransferases, the bacterial ADP‐ribosylating enzymes which do not have toxic activity, and the analogous enzymes encoded by T‐even bacteriophages. We show that, in addition to the common Glu and Arg/His amino acids previously identified, the conserved motifs can be extended as follows: (i) the Arg/His motif is usually arom‐His/Arg (where ‘arom’ is an aromatic residue); (ii) in the sequences of the CT group the β‐strand forming part of the ‘scaffold’ of the catalytic cavity has an arom‐ph‐Ser‐Thr‐Ser‐ph consensus (where ‘ph’ represents a hydrophobic residue); and (iii) the motif centred in the key glutamic residue is Glu/Gln‐X‐Glu; while (iv) in the sequences of the DT group the NAD‐binding motif is Tyr‐X10‐Tyr. We believe that the model proposed not only accounts for all ADP‐ribosylating proteins known to date, but it is likely to fit other enzymes (currently being analysed) which possess such an activity.
- 1 August 1996
- Published by Wiley in Molecular Microbiology
- Vol. 21 (4) , 667-674
Three conserved consensus sequences identify the NAD‐binding site of ADP‐ribosylating enzymes, expressed by eukaryotes, bacteria and T‐even bacteriophages
It has been previously reported that the three‐dimensional structures of the NAD‐binding and catalytic site of bacterial toxins with ADP‐ribosylating activity are superimposable, and that the key amino acids for the enzymatic activity are conserved. The model includes an NAD‐binding and catalytic site formed by an α‐helix bent over a β‐strand, surrounded by two β‐strands bearing a Glu and a His, or Arg, that are required for catalysis. We show here that the model can be extended to comprise all proteins with ADP‐ribosylating activity known to date, including all eukaryotic mono‐ and poly‐ADP‐ribosyltransferases, the bacterial ADP‐ribosylating enzymes which do not have toxic activity, and the analogous enzymes encoded by T‐even bacteriophages. We show that, in addition to the common Glu and Arg/His amino acids previously identified, the conserved motifs can be extended as follows: (i) the Arg/His motif is usually arom‐His/Arg (where ‘arom’ is an aromatic residue); (ii) in the sequences of the CT group the β‐strand forming part of the ‘scaffold’ of the catalytic cavity has an arom‐ph‐Ser‐Thr‐Ser‐ph consensus (where ‘ph’ represents a hydrophobic residue); and (iii) the motif centred in the key glutamic residue is Glu/Gln‐X‐Glu; while (iv) in the sequences of the DT group the NAD‐binding motif is Tyr‐X10‐Tyr. We believe that the model proposed not only accounts for all ADP‐ribosylating proteins known to date, but it is likely to fit other enzymes (currently being analysed) which possess such an activity.